Robyn H. Guymer
Impact in
- Ophthalmology top 0.01%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Ocular Diseases and Behçet’s Syndrome
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Retinal Imaging and Analysis
Papers in
- Ophthalmology 323
- Retinal Diseases and Treatments 306
- Retinal and Optic Conditions 45
- Glaucoma and retinal disorders 32
- Ocular Diseases and Behçet’s Syndrome 13
-
- Retinal Imaging and Analysis 102
- Co-authors
- Chi Duc Luu (87 shared papers)Zhichao Wu (88 shared papers)Paul Nigel Baird (73 shared papers)Lauren N. Ayton (48 shared papers)Robert Patrick Finger (29 shared papers)Gregory S. Hageman (11 shared papers)Thomas Gordon Campbell (2 shared papers)Sanjeewa Wickremasinghe (21 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (84 papers)Ophthalmology (50 papers)Clinical and Experimental Ophthalmology (45 papers)Ophthalmology Retina (24 papers)Eye (23 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Robyn H. Guymer
483 papers receiving 20.5k citations
Robyn H. Guymer's Hit Papers
Peers
Comparison fields: 5 of 183
- Ophthalmology 13.7k
- Radiology, Nuclear Medicine and Imaging 6.0k
- Neurology 552
- Molecular Biology 3.8k
- Biochemistry 294
Countries citing papers authored by Robyn H. Guymer
This map shows the geographic impact of Robyn H. Guymer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn H. Guymer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn H. Guymer more than expected).
Fields of papers citing papers by Robyn H. Guymer
This network shows the impact of papers produced by Robyn H. Guymer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn H. Guymer. The network helps show where Robyn H. Guymer may publish in the future.
Co-authors
The 25 scholars most cited alongside Robyn H. Guymer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 500 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants Hit paper breakdown → | 2015 | 1264 |
| 2 | Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT Hit paper breakdown → | 2017 | 717 |
| 3 | Age-related macular degeneration Hit paper breakdown → | 2021 | 703 |
| 4 | Seven new loci associated with age-related macular degeneration Hit paper breakdown → | 2013 | 672 |
| 5 | Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data Hit paper breakdown → | 2019 | 610 |
| 6 | Automatic segmentation of nine retinal layer boundaries in OCT images of non-exudative AMD patients using deep learning and graph search Hit paper breakdown → | 2017 | 421 |
| 7 | 1999 | 412 | |
| 8 | Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study Hit paper breakdown → | 2010 | 338 |
| 9 | Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study Hit paper breakdown → | 2011 | 334 |
| 10 | Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials Hit paper breakdown → | 2023 | 305 |
| 11 | Age-related macular degeneration Hit paper breakdown → | 2023 | 304 |
| 12 | 2014 | 276 | |
| 13 | Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen Hit paper breakdown → | 2018 | 256 |
| 14 | Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration Hit paper breakdown → | 2019 | 242 |
| 15 | 2014 | 228 | |
| 16 | 2011 | 223 | |
| 17 | 2010 | 215 | |
| 18 | 2015 | 208 | |
| 19 | 2017 | 198 | |
| 20 | 2006 | 179 |
About Robyn H. Guymer
Robyn H. Guymer is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Epidemiology, Molecular Biology and Cellular and Molecular Neuroscience, having authored 500 papers that have together received 21.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (306 papers), Retinal Imaging and Analysis (102 papers), Retinal and Optic Conditions (45 papers), Retinal Development and Disorders (42 papers), Glaucoma and retinal disorders (32 papers), Ophthalmology and Visual Impairment Studies (25 papers), Neuroscience and Neural Engineering (19 papers) and Ocular Diseases and Behçet’s Syndrome (13 papers). The work is most often cited by research in Ophthalmology (13.7k citations), Radiology, Nuclear Medicine and Imaging (6.0k citations), Neurology (552 citations), Molecular Biology (3.8k citations) and Biochemistry (294 citations). Robyn H. Guymer has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Chi Duc Luu, Zhichao Wu, Paul Nigel Baird, Lauren N. Ayton, Robert Patrick Finger, Gregory S. Hageman, Thomas Gordon Campbell, Sanjeewa Wickremasinghe, Mark C. Gillies and Andrea Jane Richardson. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Ophthalmology, Clinical and Experimental Ophthalmology, Ophthalmology Retina and Eye.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.